Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05748730 · ClinicalTrials.gov registry record · NA
Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention
A NA study of Adolescent Behavior and Suicide and Depression, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 900
- Enrollment target
- 13
- Study locations
NCT05748730: Recruiting NA study of Adolescent Behavior and Suicide and Depression, sponsored by University of Pittsburgh.
NCT05748730 is a NA study of Adolescent Behavior and Suicide and Depression that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 900 participants, above the 310-participant average among 46 other Adolescent Behavior trials with a reported enrollment target (190% higher). The trial reports 13 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05748730, a NA study of Adolescent Behavior and Suicide and Depression, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 900 participants
- Enrollment target
- 13
- Study locations
Study Summary
This protocol will test the effectiveness of an intervention, iCHART (integrated Care to Help At-Risk Teens) and facilitate recruitment for other studies in the larger ETUDES Center grant, which are focused on treatment development for target risk factors for suicidal behavior, specifically, sleep, anhedonia, and stress related to cybervictimization. This study will recruit 900 adolescents which will be enrolled in a randomized controlled trial to test iCHART and will be randomized to iCHART or treatment as usual (TAU). Based on previous work, the investigators hypothesize that iCHART, compared to TAU, will decrease suicidal-related events by 50%, and the effects will be mediated by increases in referrals, treatment engagement, and safety planning. The investigators will use implementation science methods to assess contextual factors (i.e., barriers and facilitators) and implementation outcomes specifically, acceptability, feasibility, appropriateness, and cost for our predictive algorithm and iCHART to inform future implementation efforts and promote health equity.
Primary Outcome
Total scores from the Patient Health Questionnaire (PHQ-9-M) will be used to assess depression severity. Total Score Depression Severity: 0-4 No or Minimal depression; 5-9 Mild depression; 10-14 Moderate depression; 15-19 Moderately severe depression; 20-27 Severe depression.
Conditions Studied
Interventions
- BEHAVIORAL iCHART
- BEHAVIORAL Treatment As Usual
Study Locations (13)
Pennsylvania
- Conemaugh Memorial Medical Center-Family Medicine - Johnstown
- CHOP Primary Care, CHOP Campus - Philadelphia
- Roxborough - Philadelphia
- CHOP Primary Care, Cobbs Creek - Philadelphia
- Karabots - Philadelphia
- Children's Community Pediatrics (CCP) of Children's Hospital of Pittsburgh UPMC - Pittsburgh
- UPMC Center for Adolescent and Young Adult Health - Pittsburgh
- UPMC Family Medicine - Pittsburgh
- Kids Plus Pediatrics (KPP) - Pittsburgh
- Berks Community Health Center - Reading
- Springfield - Springfield
- CHOP Primary Care, West Chester - West Chester
New Jersey
- Gibbsboro - Gibbsboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2023-01-26 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What NCT05748730 shows while recruiting
NCT05748730 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 310-participant average among 46 other Adolescent Behavior trials with a reported enrollment target (190% higher).
The record links to 2 conditions, with Adolescent Behavior appearing as the primary indexed condition, and to 2 interventions - of which iCHART is the first listed.
NCT05748730 lists 13 locations in 2 states (Pennsylvania, New Jersey).
Frequently Asked Questions
What is clinical trial NCT05748730 about?
NCT05748730 is a clinical study titled "Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention". This protocol will test the effectiveness of an intervention, iCHART (integrated Care to Help At-Risk Teens) and facilitate recruitment for other studies in the larger ETUDES Center grant, which are focused on treatment development for target risk factors for suicidal behavior, specifically, sleep, ...
What is the current status of trial NCT05748730?
This trial is currently recruiting. It is a NA study. The enrollment target is 900 participants. The study started on 2023-01-26. Estimated completion is 2027-04-30.
What conditions does trial NCT05748730 study?
This clinical trial studies the following conditions: Adolescent Behavior, Suicide and Depression.
What interventions are being tested in trial NCT05748730?
The interventions under investigation include: iCHART (BEHAVIORAL), Treatment As Usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT05748730?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05748730 being conducted?
This trial has 13 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adolescent Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05748730's enrollment target sits among peer trials
900 6th of 46 higher than 41 of 46 other Adolescent Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Adolescent Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Shifting Sleep Timing in Teens
RECRUITING · NA
-
Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)
RECRUITING · NA
-
Students With Involved Families and Teachers
RECRUITING · NA
-
Intervention to Enhance Coping and Help-seeking Among Youth in Foster Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI